Skip to main content

Novak Djokovic holds 80 per cent of Danish biotech developing COVID-19 treatment: CEO

Share
COPENHAGEN -

Tennis champion Novak Djokovic has an 80 per cent stake of Danish biotech firm QuantBioRes, which is aiming to develop a medical treatment to counter COVID-19, the company's chief executive told Reuters on Wednesday.

CEO Ivan Loncarevic, who described himself as an entrepreneur, said the investment was made in June 2020 but declined to say how much it was.

QuantBioRes has around 11 researchers working in Denmark, Australia and Slovenia, according to Loncarevic, who stressed they were working on a treatment, not a vaccine.

The company is developing a peptide, which inhibits the coronavirus from infecting the human cell, expects to launch clinical trials in Britain this summer, he added.

A spokesperson for Djokovic did not immediately respond to a request for comment.

The tennis number one has stoked global debate about the rights of people who opt not to get vaccinated after he was deported from Australia on Sunday night, ruling him out of the Australian Open.  

(Reporting by Nikolaj Skydsgaard;Editing by Alison Williams and Pravin Char)

CTVNews.ca Top Stories

Local Spotlight

N.B. man wins $64 million from Lotto 6/49

A New Brunswicker will go to bed Thursday night much richer than he was Wednesday after collecting on a winning lottery ticket he let sit on his bedroom dresser for nearly a year.

Record-setting pop tab collection for Ontario boy

It started small with a little pop tab collection to simply raise some money for charity and help someone — but it didn’t take long for word to get out that 10-year-old Jace Weber from Mildmay, Ont. was quickly building up a large supply of aluminum pop tabs.

Stay Connected